{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:27:41Z","timestamp":1790375261683,"version":"4.1.0"},"reference-count":60,"publisher":"BMJ","issue":"19","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,4,20]]},"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Rare neuroendocrine tumours (NETs) that most commonly arise in the gastrointestinal tract can lead to carcinoid syndrome and carcinoid heart disease. Patients with carcinoid syndrome present with vasomotor changes, hypermotility of the gastrointestinal system, hypotension and bronchospasm. Medical therapy for carcinoid syndrome, typically with somatostatin analogues, can help control symptoms, inhibit tumour progression and prolong survival. Carcinoid heart disease occurs in more than 50% of these patients and is the initial presentation of carcinoid syndrome in up to 20% of patients. Carcinoid heart disease has characteristic findings of plaque-like deposits composed of smooth muscle cells, myofibroblasts, extracellular matrix and an overlying endothelial layer which can lead to valve dysfunction. Valvular dysfunction can lead to oedema, ascites and right-sided heart failure. Medical therapy of carcinoid heart disease is limited to symptom control and palliation. Valve surgery for carcinoid heart disease should be considered for symptomatic patients with controlled metastatic carcinoid syndrome. A multidisciplinary approach is needed to guide optimal management.<\/jats:p>","DOI":"10.1136\/heartjnl-2017-311261","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T20:50:27Z","timestamp":1496955027000},"page":"1488-1495","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":64,"title":["Carcinoid heart disease"],"prefix":"10.1136","volume":"103","author":[{"given":"Saamir A","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Banchs","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar","family":"Iliescu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Dasari","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lopez-Mattei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Wamique","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"2025100707330197000_103.19.1488.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"2025100707330197000_103.19.1488.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.4.1188"},{"key":"2025100707330197000_103.19.1488.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.2.264"},{"key":"2025100707330197000_103.19.1488.4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2"},{"key":"2025100707330197000_103.19.1488.5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.CIR.29.2.253","article-title":"Carcinoid heart disease with left-sided lesions","volume":"29","author":"Schweizer","year":"1964","journal-title":"Circulation"},{"key":"2025100707330197000_103.19.1488.6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0146-2806(82)90013-5","article-title":"Carcinoid heart disease: a clinical pathologic, and therapeutic update","volume":"6","author":"Strickman","year":"1982","journal-title":"Curr Probl Cardiol"},{"key":"2025100707330197000_103.19.1488.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.01.075"},{"key":"2025100707330197000_103.19.1488.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068265"},{"key":"2025100707330197000_103.19.1488.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00354-4"},{"key":"2025100707330197000_103.19.1488.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.4.790"},{"key":"2025100707330197000_103.19.1488.11","doi-asserted-by":"publisher","DOI":"10.4065\/77.2.139"},{"key":"2025100707330197000_103.19.1488.12","doi-asserted-by":"publisher","DOI":"10.1177\/1089253212465475"},{"key":"2025100707330197000_103.19.1488.13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1051\/jbio\/2004198010022","article-title":"The 5-HT2B receptor: a main cardio-pulmonary target of serotonin","volume":"198","author":"Etienne","year":"2004","journal-title":"J Soc Biol"},{"key":"2025100707330197000_103.19.1488.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.03.008"},{"key":"2025100707330197000_103.19.1488.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1306-5"},{"key":"2025100707330197000_103.19.1488.16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4158\/EP14464.DSC","article-title":"AACE\/ACE disease state clinical review: diagnosis and management of midgut carcinoids","volume":"21","author":"Liu","year":"2015","journal-title":"Endocr Pract"},{"key":"2025100707330197000_103.19.1488.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.08.045"},{"key":"2025100707330197000_103.19.1488.18","doi-asserted-by":"publisher","DOI":"10.1161\/hc37t1.094898"},{"key":"2025100707330197000_103.19.1488.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021451"},{"key":"2025100707330197000_103.19.1488.20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11226"},{"key":"2025100707330197000_103.19.1488.21","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2001.01798.x"},{"key":"2025100707330197000_103.19.1488.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.12.025"},{"key":"2025100707330197000_103.19.1488.23","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2014.468","article-title":"Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality","volume":"111","author":"Dobson","year":"2014","journal-title":"Br J Cancer"},{"key":"2025100707330197000_103.19.1488.24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ajcn\/42.4.639","article-title":"Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid","volume":"42","author":"Feldman","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"2025100707330197000_103.19.1488.25","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.040329"},{"key":"2025100707330197000_103.19.1488.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02109-5"},{"key":"2025100707330197000_103.19.1488.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.109.886846"},{"key":"2025100707330197000_103.19.1488.28","first-page":"E4","article-title":"Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease","volume":"12","author":"Bhattacharyya","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2025100707330197000_103.19.1488.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2011.02.009"},{"key":"2025100707330197000_103.19.1488.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.rct.0000181724.69597.69"},{"key":"2025100707330197000_103.19.1488.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2008.10.013"},{"key":"2025100707330197000_103.19.1488.32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/AC.67.2.2154218","article-title":"Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance","volume":"67","author":"Moerman","year":"2012","journal-title":"Acta Cardiol"},{"key":"2025100707330197000_103.19.1488.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.8510"},{"key":"2025100707330197000_103.19.1488.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316158"},{"key":"2025100707330197000_103.19.1488.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00817-X"},{"key":"2025100707330197000_103.19.1488.36","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0173"},{"key":"2025100707330197000_103.19.1488.37","first-page":"1381","article-title":"Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors","volume":"94","author":"Frank","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2025100707330197000_103.19.1488.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.05.003"},{"key":"2025100707330197000_103.19.1488.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.014"},{"key":"2025100707330197000_103.19.1488.40","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00374-Y"},{"key":"2025100707330197000_103.19.1488.41","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90357-0"},{"key":"2025100707330197000_103.19.1488.42","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu201"},{"key":"2025100707330197000_103.19.1488.43","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90045-J"},{"key":"2025100707330197000_103.19.1488.44","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000033308.01553.2B"},{"key":"2025100707330197000_103.19.1488.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2010.10.035"},{"key":"2025100707330197000_103.19.1488.46","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev121"},{"key":"2025100707330197000_103.19.1488.47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14503\/THIJ-15-5310","article-title":"Transcatheter pulmonary valve replacement in a carcinoid Heart","volume":"43","author":"Loyalka","year":"2016","journal-title":"Tex Heart Inst J"},{"key":"2025100707330197000_103.19.1488.48","first-page":"110","article-title":"Carcinoid Heart Valve Disease: transcatheter Pulmonary Valve-In-Valve implantation in Failing Biological Xenografts","volume":"24","author":"Conradi","year":"2015","journal-title":"J Heart Valve Dis"},{"key":"2025100707330197000_103.19.1488.49","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev279"},{"key":"2025100707330197000_103.19.1488.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.12.036"},{"key":"2025100707330197000_103.19.1488.51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2044.1976.tb11796.x","article-title":"Carcinoid syndrome: its relevance to the anaesthetist","volume":"31","author":"Mason","year":"1976","journal-title":"Anaesthesia"},{"key":"2025100707330197000_103.19.1488.52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004311-199703540-00009","article-title":"Anesthesia for patients with carcinoid syndrome","volume":"35","author":"Vaughan","year":"1997","journal-title":"Int Anesthesiol Clin"},{"key":"2025100707330197000_103.19.1488.53","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000284704.57806.0b"},{"key":"2025100707330197000_103.19.1488.54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/00365528609087446","article-title":"Somatostatin analogue SMS 201-995 in type I diabetes mellitus. Initial experience after repeated administration","volume":"119","author":"Plewe","year":"1986","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2025100707330197000_103.19.1488.55","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/sj.bjc.6601816","article-title":"Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease","volume":"90","author":"Zuetenhorst","year":"2004","journal-title":"Br J Cancer"},{"key":"2025100707330197000_103.19.1488.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80586-4"},{"key":"2025100707330197000_103.19.1488.57","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-010-0758-9"},{"key":"2025100707330197000_103.19.1488.58","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezr227"},{"key":"2025100707330197000_103.19.1488.59","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.553750"},{"key":"2025100707330197000_103.19.1488.60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/jc.2015-3295","article-title":"Effect of valvular surgery in carcinoid heart disease: an observational cohort study","volume":"101","author":"Edwards","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:34:39Z","timestamp":1759847679000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":60,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2017,9,11]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/heartjnl-2017-311261"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311261","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}